Periodic Reporting for period 4 - LeukaemiaTargeted (Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine)

In Europe, around two million individuals die from cancer each year. Cancer is a genetic disease and each patient's tumour contains several genetic lesions which are identified by next generation sequencing (NGS) and influence patient's outcome. A global current challenge lies...